GRI Bio Secures New U.S. Composition of Matter Patent Covering Novel Compound Structures

Issued Claims Protect Distinct Molecular Designs with Broad Therapeutic Potential Across Inflammatory, Fibrotic, and Autoimmune DiseasesLA JOLLA, ...
JD Supra

Texas Round-Up: December 2025

Our Texas Round-Up for December 2025 covers decisions from the Eastern District addressing subject matter eligibility under ...

Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Formulation of Alprazolam – Generic Xanax(R) – for Rapid Anxiety Relief

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and ...
Commercial UAV News

Patents 101 for the Commercial Drone Industry: What They Are, Why They Matter, and How to Secure Them

Contributed by Jason Shull and Chris Galfano Innovation is the engine of the commercial drone industry. Advances in autonomy, ...
BioSpace

Renexxion Ireland Ltd. Announces Issuance of Sixth New U.S. Patent Covering New Naronapride Trihydrate Formulation, Dosage Forms, and Treatment of GI Disorders

ROSCREA, Ireland, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Renexxion Ireland Limited ("Renexxion"), a private biopharmaceutical company focused on advancing new therapies for patients with significant unmet ...
PharmiWeb

Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent EP4615820 – “Crystalline Forms of Evenamide” is expected to ...

· Evenamide is a first-in-class glutamate modulator with a novel mechanism of action for patients who do not respond adequately, or are resistant to, existing antipsychotic therapies · ENIGMA-TRS ...
Investing

CDT engages NJS Foresight to out-license solid-form patent assets

NAPLES, Fla. and CAMBRIDGE, United Kingdom - CDT Equity Inc. (NASDAQ:CDT) has engaged NJS Foresight Bio-Advisory, LLC to identify and execute out-licensing opportunities for selected assets within its ...